#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3789719	F	Antitumor activity against mouse NIH/3T3 cells expressing IGF-1 receptor implanted in athymic nude mouse assessed as tumor regression at 40 mg/kg administered twice daily for 1 week via oral gavage	Mus musculus	1	ALA3785066	organism-based format	Scientific Literature
2.	ALA3789720	F	Antitumor activity against mouse NIH/3T3 cells expressing IGF-1 receptor implanted in athymic nude mouse assessed as tumor regression at 30 mg/kg administered twice daily for 1 week via oral gavage	Mus musculus	1	ALA3785066	organism-based format	Scientific Literature
3.	ALA3789721	F	Antitumor activity against mouse NIH/3T3 cells expressing IGF-1 receptor implanted in athymic nude mouse assessed as tumor regression at 10 mg/kg administered twice daily for 1 week via oral gavage	Mus musculus	1	ALA3785066	organism-based format	Scientific Literature
4.	ALA3789722	T	Toxicity in athymic nude mouse xenografted with mouse NIH/3T3 cells expressing IGF-1 receptor assessed as body weight change at 20 mg/kg administered twice daily for 1 week via oral gavage	Mus musculus	1	ALA3785066	organism-based format	Scientific Literature
5.	ALA3789964	T	Toxicity in athymic nude mouse xenografted with mouse NIH/3T3 cells expressing IGF-1 receptor assessed as body weight change at 40 mg/kg administered twice daily for 1 week via oral gavage	Mus musculus	1	ALA3785066	organism-based format	Scientific Literature
6.	ALA3789965	T	Toxicity in athymic nude mouse xenografted with mouse NIH/3T3 cells expressing IGF-1 receptor assessed as body weight change at 30 mg/kg administered twice daily for 1 week via oral gavage	Mus musculus	1	ALA3785066	organism-based format	Scientific Literature
7.	ALA3789966	F	Antidiabetic activity in mouse assessed as insulin levels at 12.5 mg/kg/day, po for 5 days by insulin tolerance test	Mus musculus	2	ALA3785066	organism-based format	Scientific Literature
8.	ALA3789967	F	Antidiabetic activity in mouse assessed as insulin levels at 25 mg/kg/day, po for 5 days by insulin tolerance test	Mus musculus	2	ALA3785066	organism-based format	Scientific Literature
9.	ALA3789970	B	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	6	ALA3785066	single protein format	Scientific Literature
10.	ALA3789971	B	Inhibition of AXL (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	3	ALA3785066	single protein format	Scientific Literature
11.	ALA3789972	B	Inhibition of ABL1 (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	5	ALA3785066	single protein format	Scientific Literature
12.	ALA3789973	B	Inhibition of ACVR1 (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	2	ALA3785066	single protein format	Scientific Literature
13.	ALA3789974	B	Inhibition of AKT1 (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	3	ALA3785066	single protein format	Scientific Literature
14.	ALA3789975	B	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	6	ALA3785066	single protein format	Scientific Literature
15.	ALA3789976	B	Inhibition of BTK (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	6	ALA3785066	single protein format	Scientific Literature
16.	ALA3789977	B	Inhibition of CDK2A (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	6	ALA3785066	single protein format	Scientific Literature
17.	ALA3789978	B	Inhibition of CDK4D1 (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	6	ALA3785066	protein complex format	Scientific Literature
18.	ALA3789979	B	Inhibition of CSK (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	2	ALA3785066	single protein format	Scientific Literature
19.	ALA3789980	B	Inhibition of EGFR (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	2	ALA3785066	single protein format	Scientific Literature
20.	ALA3789981	B	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	Homo sapiens	6	ALA3785066	single protein format	Scientific Literature